OpenAI is reportedly developing new ChatGPT features that could directly compete with Microsoft’s Office suite, according to a report by The Information. These updates would allow users to create and edit Excel and PowerPoint-compatible files directly within the ChatGPT interface—no Microsoft apps required.
The new tools include built-in buttons within ChatGPT to help users generate spreadsheets and presentations. These files will support open-source formats, meaning OpenAI doesn’t need permission from Microsoft (NASDAQ:MSFT) to offer compatibility with Excel or PowerPoint.
In addition to document tools, OpenAI is working on advanced AI agents capable of automating complex tasks. These agents can generate reports using public or private company data, schedule meetings, and perform web-based tasks, bringing new utility to workplace automation. Such capabilities may further extend ChatGPT’s role in professional environments and increase its relevance as an all-in-one AI assistant.
This move positions ChatGPT as a growing threat to both Microsoft 365 and Google Workspace (NASDAQ:GOOGL), as it begins to blur the lines between chatbot and productivity software. While the official release date for these features has not been disclosed, the potential disruption is significant.
However, early versions of these tools may face some limitations, such as slower response times and lack of built-in storage or real-time collaboration. Still, their integration into the widely used ChatGPT platform could attract users looking for simplified, AI-powered workflows without relying on traditional productivity apps.
With this expansion, OpenAI continues its push beyond conversation and code, aiming to embed AI deeper into daily business tasks. If successful, these updates could reshape how users interact with productivity tools—and who provides them.


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



